A Cambridge startup wants to make gene therapy in a machine the size of a microwave
Tessellate Bio says its benchtop system could cut the cost of making some gene therapies by 80 percent. It has raised $46 million to prove it.
Tessellate Bio says its benchtop system could cut the cost of making some gene therapies by 80 percent. It has raised $46 million to prove it.